USCA RIA’s Clover Health Investments CLOV Stock Holding History

USCA RIA’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-150,425	Closed	-$2.52M	–	528
2020 Q4	$2.52M	Buy	+150,425	New	+$1.67M	0.18%	120

Other funds holding CLOV

GCP

Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

SIG

Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

USCA RIA's CLOV Position: Q1 2021 in Review

USCA RIA sold out of Clover Health Investments (CLOV) in Q1 2021, closing a stake of 150,425 shares — an estimated $2.52M sold.

USCA RIA first reported a position in CLOV in Q4 2020 and held it in 1 quarter. The position peaked at $2.52M in Q4 2020. 137 funds tracked by Wall St. Rank hold CLOV as of Q1 2021.

USCA RIA reported no remaining Clover Health Investments position as of Q1 2021 after selling out during the quarter.
USCA RIA sold 150,425 Clover Health Investments shares in Q1 2021, an estimated $2.52M.
USCA RIA first reported a position in Clover Health Investments in Q4 2020 and held it in 1 quarter.
USCA RIA's Clover Health Investments position peaked at $2.52M in Q4 2020.
137 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2021.

Based on USCA RIA's 13F filing for Q1 2021, filed 27 Apr 2021.